Name | ethyl 4-methyl-2-[3-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylate |
---|---|
Synonyms |
1G-311S
4-methyl-2-(3-trifluoromethyl-phenyl)-thiazole-5-carboxylic acid ethyl ester ethyl 4-methyl-2-[3-(trifluoromethyl)phenyl]thiazole-5-carboxylate |
Molecular Formula | C14H12F3NO2S |
---|---|
Molecular Weight | 315.31100 |
Exact Mass | 315.05400 |
PSA | 67.43000 |
LogP | 4.31400 |
HS Code | 2934100090 |
---|
~99% 144061-14-3 |
Literature: Takeda Pharmaceutical Company Limited Patent: EP2264017 A1, 2010 ; Location in patent: Page/Page column 170 ; |
~72% 144061-14-3 |
Literature: Ackermann, Jean; Aebi, Johannes; Binggeli, Alfred; Grether, Uwe; Hirth, Georges; Kuhn, Bernd; Maerki, Hans-Peter; Meyer, Markus; Mohr, Peter; Wright, Matthew Blake Patent: US2005/4187 A1, 2005 ; Location in patent: Page 23 ; |
~% 144061-14-3 |
Literature: Journal of Medicinal Chemistry, , vol. 50, # 4 p. 685 - 695 |
Precursor 4 | |
---|---|
DownStream 2 | |
HS Code | 2934100090 |
---|---|
Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |